Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyMon, 10 Jun 2024 13:26:24 +0200Tue, 06 Feb 2024 14:47:00 +0100Human medicines European public assessment report (EPAR): Xenpozyme, olipudase alfa, Date of authorisation: 24/06/2022, Revision: 3, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/xenpozymeHuman medicines European public assessment report (EPAR): Xenpozyme, olipudase alfa, Date of authorisation: 24/06/2022, Revision: 3, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/xenpozymeTue, 06 Feb 2024 14:47:00 +0100Human medicineXenpozyme : Orphan maintenance assessment report (initial authorisation)https://www.ema.europa.eu/system/files/documents/orphan-maintenance-report/xenpozyme-orphan-maintenance-assessment-report_en.pdfXenpozyme : Orphan maintenance assessment report (initial authorisation)https://www.ema.europa.eu/system/files/documents/orphan-maintenance-report/xenpozyme-orphan-maintenance-assessment-report_en.pdfWed, 27 Jul 2022 13:55:00 +0200Human medicine